# Optimization of Treatment in Patients With Severe Peripheral Ischemia (Fontaine Stage IIb)

> **NCT01718288** · PHASE4 · COMPLETED · sponsor: **Fadoi Foundation, Italy** · enrollment: 150 (actual)

## Conditions studied

- Peripheral Arterial Disease

## Interventions

- **DRUG:** iloprost
- **DRUG:** Standard Treatment (aspirin.....),

## Key facts

- **NCT ID:** NCT01718288
- **Lead sponsor:** Fadoi Foundation, Italy
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2011-03
- **Final completion:** 2012-04
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2012-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01718288

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01718288, "Optimization of Treatment in Patients With Severe Peripheral Ischemia (Fontaine Stage IIb)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01718288. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*